Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1232)	7/15/2005 4:02:35 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

DYAX Is up for 2nd day on a roll. It showed a 213% improvement on earning on the 1st Q ($0.27 on the black vs. a loss of $0.24/shr in 2004) and that was in spite of its revenues down 35% (3.7M vs. 5.7M) The stock is trading above its May 27 H of $ and seems ready to test its May 11 H at 5.60 <g> DYAX reportedly has around $1.55 in cash/shr, its Debt/Equity is around 0.13 BV around $1.25 The insiders hold more than 10% It is expected to start a PIII of its DX88 later this year. The stock has been up about 5.5% today and volume is more than 486Ks. bigcharts.marketwatch.com Bernard